Clinical Trial Update: Epidemiological and Scientific Evaluation of EGFR Mutation Status in Patients With Newly Diagnosed Locally Advanced or m

View source ↗

Summary

This clinical trial update provides an epidemiological and scientific evaluation of EGFR mutation status in patients with newly diagnosed locally advanced or me…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: AstraZeneca | Conditions: Newly Diagnosed Locally Advanced or Metastatic Non-small Cell Lung Cancer | Status: COMPLETED